Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

Walsh, Dominic M., Klyubin, Igor, Fadeeva, Julia V., Cullen, William K., Anwyl, Roger, Wolfe, Michael S., Rowan, Michael J., Selkoe, Dennis J.·2002·Nature

Cited by (1,067)

Items 401–500 of 1,067

  1. Intrinsic disorder in proteins associated with neurodegenerative diseases
    N. Vladimir · 2009 · Frontiers in bioscience
  2. The roles of TNF in brain dysfunction and disease
    Ian A. Clark, Lisa M. Alleva, Bryce Vissel · 2010 · Pharmacology & Therapeutics
  3. Molecular and Cellular Basis of Neurodegeneration in Alzheimer’s Disease
    Sangyun Jeong · 2017 · Molecules and Cells
  4. A Role for Synaptic Zinc in Activity-Dependent Aβ Oligomer Formation and Accumulation at Excitatory Synapses
    Deshpande, Atul, Kawai, Hideki, Metherate, Raju, Glabe, Charles G., Busciglio, Jorge · 2009 · The Journal of Neuroscience
  5. Site-specific Inhibitory Mechanism for Amyloid β42 Aggregation by Catechol-type Flavonoids Targeting the Lys Residues
    Mizuho Sato, Kazuma Murakami, Mayumi Uno, Yu Nakagawa, Sumie Katayama, Ken‐ichi Akagi, Yuichi Masuda, K. Takegoshi, Kazuhiro Irie · 2013 · Journal of Biological Chemistry
  6. High-fat diet-induced memory impairment in triple-transgenic Alzheimer’s disease (3xTgAD) mice is independent of changes in amyloid and tau pathology.
    Knight, Elysse M., Martins, Isaura V.A., Gümüsgöz, Sarah, Allan, Stuart M., Lawrence, Catherine B. · 2014 · Neurobiology of Aging
  7. Atherosclerosis, dementia, and Alzheimer disease in the Baltimore Longitudinal Study of aging cohort
    Hillary Dolan, Barbara J. Crain, Juan Carlos Troncoso, Susan M. Resnick, Alan B. Zonderman, Richard O’Brien · 2010 · Annals of Neurology
  8. High-resolution Atomic Force Microscopy of Soluble Aβ42 Oligomers
    Iris A. Mastrangelo, Mahiuddin Ahmed, Takeshi Sato, Wei Liu, Chengpu Wang, Paul V. C. Hough, Steven O. Smith · 2006 · Journal of Molecular Biology
  9. Calcium signaling in Alzheimer's disease & therapies
    Benjamin Chun‐Kit Tong, Aston Jiaxi Wu, Min Li, King‐Ho Cheung · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  10. Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer’s disease
    Atamna, Hani, Frey, William H. · 2007 · Mitochondrion
  11. Amyloid-beta precursor protein processing in neurodegeneration
    Valérie Wilquet, Bart De Strooper · 2004 · Current Opinion in Neurobiology
  12. Evidence for Proteotoxicity in β Cells in Type 2 Diabetes
    Tatyana Gurlo, Sergey Ryazantsev, Chang-jiang Huang, Michael W. Yeh, Howard A. Reber, Oscar Joe Hines, Timothy D. O’Brien, Charles G. Glabe, Peter C. Butler · 2009 · American Journal Of Pathology
  13. Human neprilysin is capable of degrading amyloid β peptide not only in the monomeric form but also the pathological oligomeric form
    Hyoe Kanemitsu, Takami Tomiyama, Hiroshi Mori · 2003 · Neuroscience Letters
  14. Soluble Amyloid Oligomers Increase Bilayer Conductance by Altering Dielectric Structure
    Yuri Sokolov, J. Ashot Kozak, Rakez Kayed, Alexandr Chanturiya, Charles G. Glabe, James E. Hall · 2006 · The Journal of General Physiology
  15. Detection of elevated levels of soluble -synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies
    Katerina E. Paleologou, Christine Lund Kragh, David M. A. Mann, S. A. Salem, Rania Al‐Shami, David Allsop, Azza H.M. Hassan, Poul Henning Jensen, Omar M. A. El‐Agnaf · 2008 · Brain
  16. Antimicrobial Properties of Amyloid Peptides
    Bruce L. Kagan, Hyunbum Jang, Ricardo F. Capone, Fernando Terán Arce, Srinivasan Ramachandran, Ratnesh Lal, Ruth Nussinov · 2011 · Molecular Pharmaceutics
  17. Amyloid β-Protein Toxicity and the Pathogenesis of Alzheimer Disease
    Bruce A. Yankner, Tao Lu · 2008 · Journal of Biological Chemistry
  18. The Polyphenol Oleuropein Aglycone Protects TgCRND8 Mice against Aß Plaque Pathology
    Cristina Grossi, Stefania Rigacci, Stefano Ambrosini, Teresa Ed Dami, Ilaria Luccarini, Chiara Traini, Paola Failli, Andrea Berti, Fiorella Casamenti, Massimo Stefani · 2013 · PLoS ONE
  19. Mutations that Reduce Aggregation of the Alzheimer's Aβ42 Peptide: an Unbiased Search for the Sequence Determinants of Aβ Amyloidogenesis
    Christine Wurth, Nathalie K. Guimard, Michael H. Hecht · 2002 · Journal of Molecular Biology
  20. What Happens with the Circuit in Alzheimer's Disease in Mice and Humans?
    Benedikt Zott, Marc Aurel Busche, Reisa Anne Sperling, Arthur Konnerth · 2018 · Annual Review of Neuroscience
  21. Peripheral Aβ subspecies as risk biomarkers of Alzheimer's disease
    Schupf, Nicole, Tang, Ming X., Fukuyama, Hide, Manly, Jennifer, Andrews, Howard, Mehta, Pankaj, Ravetch, Jeffery, Mayeux, Richard · 2008 · Proceedings of the National Academy of Sciences
  22. The relationship between stress and Alzheimer's disease
    Justice, Nicholas J. · 2018 · Neurobiology of Stress
  23. Neurotoxicity and physicochemical properties of Abeta mutant peptides from cerebral amyloid angiopathy: implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease.
    K. Murakami, K. Irie, A. Morimoto, H. Ohigashi, M. Shindo, M. Nagao, Takahiko Shimizu, T. Shirasawa · 2003 · Journal of Biological Chemistry
  24. Prevention of Alzheimer's disease: Omega-3 fatty acid and phenolic anti-oxidant interventions
    Greg M. Cole, Giselle P. Lim, Fusheng Yang, Bruce Teter, Aynun Nahar Begum, Qiu‐Lan Ma, Marni E. Harris‐White, Sally Ann Frautschy · 2005 · Neurobiology of Aging
  25. Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer’s disease
    Dag Sehlin, Xiaotian T. Fang, Linda Cato, Gunnar Antoni, Lars Lannfelt, Stina Syvänen · 2016 · Nature Communications
  26. Treatment of neurodegenerative disorders through the blood–brain barrier using nanocarriers
    Nitya Poovaiah, Z. Davoudi, Haibao Peng, Benjamin William Schlichtmann, Surya K. Mallapragada, Balaji Narasimhan, Qun Wang · 2018 · Nanoscale
  27. AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice
    Chang, Eric H., Savage, Mary J., Flood, Dorothy G., Thomas, Justin M., Levy, Robert B., Mahadomrongkul, Veeravan, Shirao, Tomoaki, Aoki, Chiye, Huerta, Patricio T. · 2006 · Proceedings of the National Academy of Sciences
  28. Presenilin and nicastrin regulate each other and determine amyloid β-peptide production via complex formation
    Dieter Edbauer, Edith Winkler, Christian Haass, Harald Steiner · 2002 · Proceedings of the National Academy of Sciences
  29. Neurons derived from sporadic Alzheimer’s disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation
    Ochalek, Anna, Mihalik, Balázs, Avci, Hasan X., Chandrasekaran, Abinaya, Téglási, Annamária, Bock, István, Giudice, Maria Lo, Táncos, Zsuzsanna, Molnár, Kinga, László, Lajos et al. · 2017 · Alzheimer's Research & Therapy
  30. Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer’s disease
    Ling, Yan, Morgan, Kevin, Kalsheker, Noor · 2003 · The International Journal of Biochemistry & Cell Biology
  31. Conformational Differences between Two Amyloid β Oligomers of Similar Size and Dissimilar Toxicity
    Ali Reza A. Ladiwala, Jeffrey Litt, Ravi S. Kane, Darryl Aucoin, Steven O. Smith, Swarnim Ranjan, Judianne Davis, William E. Van Nostrand, Peter M. Tessier · 2012 · Journal of Biological Chemistry
  32. Role of Copper in the Onset of Alzheimer’s Disease Compared to Other Metals
    Soghra Bagheri, Rosanna Squitti, Thomas Haertlé, Mariacristina Siotto, Ali Akbar Saboury · 2018 · Frontiers in Aging Neuroscience
  33. Risk Factors for Dementia
    Chen, Jen-Hau, Lin, Kun-Pei, Chen, Yen-Ching · 2009 · Journal of the Formosan Medical Association
  34. Chronic Neurodegeneration After Traumatic Brain Injury: Alzheimer Disease, Chronic Traumatic Encephalopathy, or Persistent Neuroinflammation?
    Faden, Alan I., Loane, David J. · 2015 · Neurotherapeutics
  35. Aβ-Mediated NMDA Receptor Endocytosis in Alzheimer's Disease Involves Ubiquitination of the Tyrosine Phosphatase STEP 61
    Pradeep K. Kurup, Yongfang Zhang, Jian Xu, Deepa V. Venkitaramani, Vahram H. Haroutunian, Paul Greengard, Angus Clark Nairn, Paul J. Lombroso · 2010 · Journal of Neuroscience
  36. β-Amyloid Peptide at Sublethal Concentrations Downregulates Brain-Derived Neurotrophic Factor Functions in Cultured Cortical Neurons
    Tong, Liqi, Balazs, Robert, Thornton, Phillip L., Cotman, Carl W. · 2004 · The Journal of Neuroscience
  37. Differential effects of oligomeric and fibrillar amyloid-β1–42 on astrocyte-mediated inflammation
    Jill A. White, Arlene M. Manelli, Kristina H. Holmberg, Linda J. Van Eldik, Mary Jo LaDu · 2005 · Neurobiology of Disease
  38. Progressive accumulation of amyloid‐ β oligomers in Alzheimer’s disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins
    Emiley Pham, Leslie A. Crews, Kiren K. Ubhi, Lawrence A. Hansen, Anthony Adame, Anna E. Cartier, David P. Salmon, Douglas R Galasko, Sarah Michael, Jeffrey N. Savas et al. · 2010 · FEBS Journal
  39. Metabolism of amyloid-β peptide and Alzheimer's disease
    Nobuhisa Iwata, Makoto Higuchi, Takaomi C. Saido · 2005 · Pharmacology & Therapeutics
  40. Cyclooxygenase-2 inhibition improves amyloid-β-mediated suppression of memory and synaptic plasticity
    Linda Kotilinek, Marcus A. Westerman, Qinwen Wang, Kimberly L. Panizzon, Giselle P. Lim, Ágnes Simonyi, Sylvain Lesné, Agnieszka M. Falinska, Linda H. Younkin, Steven G. Younkin et al. · 2008 · Brain
  41. Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity
    Hideki Sakahira, Peter Breuer, Manajit K. Hayer-Hartl, F. Ulrich Hartl · 2002 · Proceedings of the National Academy of Sciences
  42. Neuronal Mitophagy in Neurodegenerative Diseases
    Marta Martínez‐Vicente · 2017 · Frontiers in Molecular Neuroscience
  43. Methionine 35 Oxidation Reduces Fibril Assembly of the Amyloid Aβ-(1–42) Peptide of Alzheimer's Disease
    Liming Hou, Inkyung Kang, Roger E. Marchant, Michael G. Zagorski · 2002 · Journal of Biological Chemistry
  44. Truncated beta‐amyloid peptide species in pre‐clinical Alzheimer's disease as new targets for the vaccination approach
    Nicolas Sergeant, Stepanie Bombois, Antoine Ghestem, Hervé Drobecq, Vesna Kostanjevečki, Carla Missiaen, Annick Wattez, Jean Philippe David, Eugeen Vanmechelen, Christian Sergheraert et al. · 2003 · Journal of Neurochemistry
  45. Three-Dimensional Study of Alzheimer’s Disease Hallmarks Using the iDISCO Clearing Method
    Liebmann, Thomas, Renier, Nicolas, Bettayeb, Karima, Greengard, Paul, Tessier-Lavigne, Marc, Flajolet, Marc · 2016 · Cell Reports
  46. Decreased Brain-Derived Neurotrophic Factor Depends on Amyloid Aggregation State in Transgenic Mouse Models of Alzheimer's Disease
    Shiyong Peng, Diego J. Garzon, Monica Marchese, William L. Klein, Stephen D. Ginsberg, Beverly M. Francis, Howard T.J. Mount, Elliott Jay Mufson, Ahmad Salehi, Margaret L. Fahnestock · 2009 · Journal of Neuroscience
  47. Lipid Rafts: Linking Alzheimer′s Amyloid‐βProduction, Aggregation, and Toxicity at Neuronal Membranes
    Jo V. Rushworth, Nigel M. Hooper · 2010 · International Journal of Alzheimer s Disease
  48. Mesenchymal stem cells and cell-derived extracellular vesicles protect hippocampal neurons from oxidative stress and synapse damage induced by amyloid-β oligomers
    de Godoy, Mariana A., Saraiva, Leonardo M., de Carvalho, Luiza R.P., Vasconcelos-dos-Santos, Andreia, Beiral, Hellen J.V., Ramos, Alane Bernardo, Silva, Livian R. de Paula, Leal, Renata B., Monteiro, Victor H.S., Braga, Carolina V. et al. · 2018 · Journal of Biological Chemistry
  49. Tau-dependent microtubule disassembly initiated by prefibrillar β-amyloid
    Michelle E. King, Ho-Man Kan, Peter W. Baas, Alev Erişir, Charles G. Glabe, George S. Bloom · 2006 · The Journal of Cell Biology
  50. Truncated β-amyloid peptide channels provide an alternative mechanism for Alzheimer’s Disease and Down syndrome
    Hyunbum Jang, Fernando Terán Arce, Srinivasan Ramachandran, Ricardo F. Capone, Rushana Azimova, Bruce L. Kagan, Ruth Nussinov, Ratnesh Lal · 2010 · Proceedings of the National Academy of Sciences
  51. Amyloid- Peptide Oligomers Disrupt Axonal Transport through an NMDA Receptor-Dependent Mechanism That Is Mediated by Glycogen Synthase Kinase 3 in Primary Cultured Hippocampal Neurons
    H. Decker, K.Y. Lo, S. M. Unger, Sergio Teixeira Ferreira, Michael A Silverman · 2010 · Journal of Neuroscience
  52. Mysterious oligomerization of the amyloidogenic proteins
    Vladimir Nikolaevich Uversky · 2010 · FEBS Journal
  53. Memantine Improves Cognition and Reduces Alzheimer’s-Like Neuropathology in Transgenic Mice
    Hilda Martínez‐Coria, Kim N. Green, Lauren M. Billings, Masashi Kitazawa, Miriam Albrecht, Gerhard Rammes, Chris G. Parsons, Sandeep Gupta, Pradeep Banerjee, Frank M. LaFerla · 2009 · American Journal Of Pathology
  54. Early neuropathology of somatostatin/NPY GABAergic cells in the hippocampus of a PS1×APP transgenic model of Alzheimer's disease
    Blanca Ramos, David Baglietto‐Vargas, Juan Carlos del Río, Inés Moreno‐González, Consuelo Santa‐María, Sebastián Jiménez, Cristina Caballero, Juan Felix Lopez-Tellez, Zafar U. Khan, Diego Ruano et al. · 2005 · Neurobiology of Aging
  55. The role of the immune system in Alzheimer disease: Etiology and treatment
    Stefan D. Jevtic, Ameet S. Sengar, Michael W. Salter, JoAnne McLaurin · 2017 · Ageing Research Reviews
  56. Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease
    Ricobaraza, Ana, Cuadrado‐Tejedor, Mar, Marco, Sonia, Pérez‐Otaño, Isabel, García‐Osta, Ana · 2012 · Hippocampus
  57. Physicochemical interactions of amyloid β-peptide with lipid bilayers
    Katsumi Matsuzaki · 2007 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  58. Structural Reorganisation and Potential Toxicity of Oligomeric Species Formed during the Assembly of Amyloid Fibrils
    Mookyung Cheon, Iksoo Chang, Sandipan Mohanty, Leila M. Luheshi, Christopher Martin Dobson, Michele Vendruscolo, Giorgio Favrin · 2007 · PLoS Computational Biology
  59. CNS expression of anti‐inflammatory cytokine interleukin‐4 attenuates Alzheimer's disease‐like pathogenesis in APP+PS1 bigenic mice
    Kiyota, Tomomi, Okuyama, Satoshi, Swan, Russell J., Jacobsen, Michael T., Gendelman, Howard E., Ikezu, Tsuneya · 2010 · The FASEB Journal
  60. Scara1 deficiency impairs clearance of soluble amyloid-β by mononuclear phagocytes and accelerates Alzheimer’s-like disease progression
    Frenkel, Dan, Wilkinson, Kim, Zhao, Lingzhi, Hickman, Suzanne E., Means, Terry K., Puckett, Lindsay, Farfara, Dorit, Kingery, Nathan D., Weiner, Howard L., El Khoury, Joseph · 2013 · Nature Communications
  61. Soluble oligomers of amyloid-β peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway
    Catherine Malaplate, Sabrina Florent‐Béchard, Ihsen Youssef, Violette Koziel, Isabelle Sponne, Badreddine Kriem, Brigitte Leininger‐Muller, J L Olivier, Thierry Oster, Thierry Pillot · 2006 · Neurobiology of Disease
  62. Behavioral assays with mouse models of Alzheimer's disease: Practical considerations and guidelines
    Daniela Puzzo, Linda S. Lee, Agostino Palmeri, Giorgio Calabrese, Ottavio Arancio · 2014 · Biochemical Pharmacology
  63. Fluid biomarkers in Alzheimer’s disease – current concepts
    Christoffer Rosén, Oskar Hansson, Kaj Blennow, Henrik Zetterberg · 2013 · Molecular Neurodegeneration
  64. Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death
    Wang, Xiaonan, Hu, Xuejun, Yang, Yang, Takata, Toshihiro, Sakurai, Takashi · 2016 · Brain Research
  65. Soluble Aβ Oligomers Are Rapidly Sequestered from Brain ISF In Vivo and Bind GM1 Ganglioside on Cellular Membranes
    Hong, Soyon, Ostaszewski, Beth L., Yang, Ting, O’Malley, Tiernan T., Jin, Ming, Yanagisawa, Katsuhiko, Li, Shaomin, Bartels, Tim, Selkoe, Dennis J. · 2014 · Neuron
  66. Acute γ-Secretase Inhibition Improves Contextual Fear Conditioning in the Tg2576 Mouse Model of Alzheimer's Disease
    T. Comery, R. Martone, S. Aschmies, K. Atchison, G. Diamantidis, Xiao-Hai Gong, Hua Zhou, A. Kreft, M. Pangalos, June Sonnenberg-Reines et al. · 2005 · Journal of Neuroscience
  67. Wnt signaling in neuroprotection and stem cell differentiation
    Enrique M. Toledo, Marcela Colombres, Nibaldo C. Inestrosa · 2008 · Progress in Neurobiology
  68. Cortical Synaptic Integration<i>In Vivo</i>Is Disrupted by Amyloid-β Plaques
    Stern, Edward A., Bacskai, Brian J., Hickey, Gregory A., Attenello, Frank J., Lombardo, Julianne A., Hyman, Bradley T. · 2004 · The Journal of Neuroscience
  69. Molecular reorganization of endocannabinoid signalling in Alzheimer’s disease
    Jan Mulder, Misha Y. Zilberter, Susana J. Pasquaré, Alán Alpár, Gunnar Schulte, Samira G. Ferreira, Attila Köfalvi, Ana María Martín-Moreno, Erik Keimpema, Heikki Tanila et al. · 2011 · Brain
  70. Chemical Fluorescent Probe for Detection of Aβ Oligomers
    Chai Lean Teoh, Dongdong Su, Srikanta Sahu, Seong‐Wook Yun, Eleanor Drummond, Frances C. Prelli, Sulgi Lim, Sunhee Cho, Sihyun Ham, Thomas Wısnıewskı et al. · 2015 · Journal of the American Chemical Society
  71. Systemic Catabolism of Alzheimer's Aβ40 and Aβ42
    Ghiso, Jorge, Shayo, Marcos, Calero, Miguel, Ng, Douglas, Tomidokoro, Yasushi, Gandy, Samuel, Rostagno, Agueda, Frangione, Blas · 2004 · Journal of Biological Chemistry
  72. Amyloid-β peptide (Aβ) neurotoxicity is modulated by the rate of peptide aggregation: Aβ dimers and trimers correlate with neurotoxicity
    Hung, Lin Wai, Ciccotosto, Giuseppe D., Giannakis, Eleni, Tew, Deborah J., Perez, Keyla, Masters, Colin L., Cappai, Roberto, Wade, John D., Barnham, Kevin J. · 2008 · The Journal of Neuroscience
  73. Selective neuronal degeneration induced by soluble oligomeric amyloid beta‐protein
    Hyeon‐Jin Kim, Soo‐Cheon Chae, Dae‐Kwon Lee, Brett A. Chromy, Sam Cheol Lee, Yeong‐Chul Park, William L. Klein, Grant A. Krafft, Seong‐Tshool Hong · 2002 · The FASEB Journal
  74. Platinum-based inhibitors of amyloid-β as therapeutic agents for Alzheimer's disease
    Kevin Jeffrey Barnham, Vijaya B. Kenche, Giuseppe D. Ciccotosto, David P. Smith, Deborah J. Tew, Xiang Liu, Keyla A. Perez, Greg A. Cranston, Timothy Johanssen, Irene Volitakis et al. · 2008 · Proceedings of the National Academy of Sciences
  75. Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain
    David Allan Butterfield · 2004 · Brain Research
  76. Alzheimer‐associated Aβ oligomers impact the central nervous system to induce peripheral metabolic deregulation
    Clarke, Julia R, Lyra e Silva, Natalia M, Figueiredo, Claudia P, Frozza, Rudimar L, Ledo, Jose H, Beckman, Danielle, Katashima, Carlos K, Razolli, Daniela, Carvalho, Bruno M, Frazão, Renata et al. · 2015 · EMBO Molecular Medicine
  77. Copper(II) Binding to Amyloid-β Fibrils of Alzheimer’s Disease Reveals a Picomolar Affinity: Stoichiometry and Coordination Geometry Are Independent of Aβ Oligomeric Form
    Claire J. Sarell, Christopher D. Syme, Stephen E. J. Rigby, John H. Viles · 2009 · Biochemistry
  78. Ion Channel Formation by Amyloid-β42 Oligomers but Not Amyloid-β40 in Cellular Membranes
    David C. Bode, Mark D. Baker, John H. Viles · 2016 · Journal of Biological Chemistry
  79. Age effects on the regulation of adult hippocampal neurogenesis by physical activity and environmental enrichment in the APP23 mouse model of Alzheimer disease
    Sebastián Mirochnic, Susanne A. Wolf, Matthias Staufenbiel, Gerd Kempermann · 2009 · Hippocampus
  80. Converging Pathogenic Mechanisms in Vascular and Neurodegenerative Dementia
    Costantino Iadecola, Philip B. Gorelick · 2003 · Stroke
  81. Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease
    Fabrizio Trinchese, Mauro Fà, Shumin Liu, Hong Zhang, Ariel Hidalgo, Stephen D. Schmidt, Hisako Yamaguchi, Narihiko Yoshii, Paul M. Mathews, Ralph A. Nixon et al. · 2008 · Journal of Clinical Investigation
  82. Metals ions and neurodegeneration
    Francisco Molina‐Holgado, Robert C. Hider, Alessandra Gaeta, Robert Williams, Paul T. Francis · 2007 · BioMetals
  83. Blockade of EphA4 signaling ameliorates hippocampal synaptic dysfunctions in mouse models of Alzheimer’s disease
    Fu, Amy K. Y., Hung, Kwok-Wang, Huang, Huiqian, Gu, Shuo, Shen, Yang, Cheng, Elaine Y. L., Ip, Fanny C. F., Huang, Xuhui, Fu, Wing-Yu, Ip, Nancy Y. · 2014 · Proceedings of the National Academy of Sciences
  84. The role of cell-derived oligomers of Aβ in Alzheimer's disease and avenues for therapeutic intervention
    D.M. Walsh, I. Klyubin, G.M. Shankar, Matthew Townsend, Julia V. Fadeeva, Vicki Betts, Marcia Berman Podlisny, James P. Cleary, Karen H. Ashe, Michael J. Rowan et al. · 2005 · Biochemical Society Transactions
  85. Molecular Mechanism of the Inhibition of EGCG on the Alzheimer Aβ1–42Dimer
    Tong Zhang, Jian Zhang, Philippe Derreumaux, Yuguang Mu · 2013 · The Journal of Physical Chemistry B
  86. An ALS-Linked Mutant SOD1 Produces a Locomotor Defect Associated with Aggregation and Synaptic Dysfunction When Expressed in Neurons of Caenorhabditis elegans
    Jiou Wang, George W. Farr, David H. Hall, Fei Li, Krystyna Furtak, Lars Dreier, Arthur L. Horwich · 2009 · PLoS Genetics
  87. Lysozyme Amyloid Oligomers and Fibrils Induce Cellular Death via Different Apoptotic/Necrotic Pathways
    Anna L. Gharibyan, Vladimir Zamotin, Kiran Yanamandra, O. S. Moskaleva, Boris A. Margulis, Irina A. Kostanyan, Ludmilla A. Morozova‐Roche · 2006 · Journal of Molecular Biology
  88. Chaperoning brain degeneration
    Nancy M. Bonini · 2002 · Proceedings of the National Academy of Sciences
  89. Amyloid beta ion channel: 3D structure and relevance to amyloid channel paradigm
    Ratnesh Lal, Hai Lin, Arjan Pieter Quist · 2007 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  90. Does Alzheimer's disease begin in the brainstem?
    Simic, G., Stanic, G., Mladinov, M., Jovanov‐Milosevic, N., Kostovic, I., Hof, P. R. · 2009 · Neuropathology and Applied Neurobiology
  91. Loss of α7 Nicotinic Receptors Enhances β-Amyloid Oligomer Accumulation, Exacerbating Early-Stage Cognitive Decline and Septohippocampal Pathology in a Mouse Model of Alzheimer's Disease
    Hernandez, Caterina M., Kayed, Rakez, Zheng, Hui, Sweatt, J. David, Dineley, Kelly T. · 2010 · The Journal of Neuroscience
  92. The green tea polyphenol (−)‐epigallocatechin gallate prevents the aggregation of tau protein into toxic oligomers at substoichiometric ratios
    Heike J. Wobst, Apurwa M Sharma, Marc I. Diamond, Erich E. Wanker, Jan Bieschke · 2014 · FEBS Letters
  93. Synaptic Vulnerability in Neurodegenerative Disease
    Thomas M. Wishart, Simon H. Parson, Thomas Henry Gillingwater · 2006 · Journal of Neuropathology & Experimental Neurology
  94. RETRACTED: Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer's disease by reduction of oxidative stress
    Jian Li, Cai Wang, John H. Zhang, Jianmei Cai, Yunpeng Cao, Xuejun Sun · 2010 · Brain Research · Retracted
  95. Deciphering the genesis and fate of amyloid β-protein yields novel therapies for Alzheimer disease
    Dennis J. Selkoe · 2002 · Journal of Clinical Investigation
  96. Calcium dysregulation in Alzheimer's disease
    Łukasz Bojarski, Jochen Wolfgang Herms, Jacek Kuźnicki · 2007 · Neurochemistry International
  97. Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: A magnetic resonance microscopy and stereologic analysis
    Jeffrey M. Redwine, Barry E. Kosofsky, Russell E. Jacobs, Dora Games, John F. Reilly, John H. Morrison, Warren G. Young, Floyd E. Bloom · 2003 · Proceedings of the National Academy of Sciences
  98. Synaptic plasticity in animal models of early Alzheimer's disease
    Michael J. Rowan, Igor V. Klyubin, William K. Cullen, Roger Anwyl · 2003 · Philosophical Transactions of the Royal Society B Biological Sciences
  99. Molecular links between Alzheimer’s disease and diabetes mellitus
    Yiyi Yang, Weihong Song · 2013 · Neuroscience
  100. Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-β-Mediated Cortical Synaptic Dysfunction
    Nicola Origlia, Massimo Righi, Simona Capsoni, Antonino Cattaneo, Fang Fang, David M. Stern, John Xi Chen, Ann Marie Schmidt, Ottavio Arancio, Shi Du Yan et al. · 2008 · Journal of Neuroscience